Design of Experiments (DOE)

Design of Experiments (DOE) represents a systematic statistical methodology for planning, conducting, and analysing controlled experiments to understand relationships between multiple input variables and measured responses while maximising information gained from minimum experimental effort. This powerful approach employs structured experimental designs including factorial, fractional factorial, response surface, and optimal designs that enable efficient evaluation of numerous factors simultaneously, quantify interaction effects between variables, and establish mathematical models predicting outcomes across experimental spaces.

The biopharmaceutical industry widely adopts DOE throughout development and manufacturing optimisation. Process development employs DOE identifying critical process parameters affecting product quality, establishing operating ranges supporting robust manufacturing, and creating design spaces within which changes require minimal regulatory oversight. Formulation development uses DOE optimising excipient combinations, concentrations, and processing conditions maximising stability and performance. Analytical method development applies DOE understanding how variables like pH, temperature, or mobile phase composition affect method performance. Quality by Design initiatives mandate DOE demonstrating process understanding and control strategy justification in regulatory submissions. Advantages include efficiency by evaluating multiple factors simultaneously, quantifying interaction effects invisible to traditional methods, and establishing predictive models enabling in silico optimisation. As manufacturing processes become increasingly complex with continuous processing, intensified operations, and novel modalities, DOE remains essential methodology driving efficient development, robust manufacturing, and regulatory confidence.